Pharmaceutical Technology, Sep 1, 2009 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Sep 1, 2009
Articles
Using Microreactors in Chemical Synthesis: Batch Process versus Continuous Flow
By Andreas Weiler , Matthias Junkers
The authors discuss the advantages of microreactors and flow chemistry for various reaction types in achieving improved process economics and reaction efficiency.
Moving from Vial to Prefilled Syringe
By Raul Soikes
A Project Manager's Perspective.
Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
By Rosie McLaughlin , Susan Banbury , Kieran Crowley
The authors describe the various available technologies used in orally disintegrating tablets.
Market Outlook for Biosimilars
By Bornadata Bain
The author reviews the major biopharmaceutical markets' activity and predicts how the markets may evolve.
Applying Biocatalysis: A Technical Forum
By Patricia Van Arnum
Scientists from DSM and Kaneka discuss various techniques in this roundtable moderated by Patricia Van Arnum.
Design and Construction of a Potent Pharmaceutical CGMP Suite
By Joe Cascone
The author describes the approach taken to develop a facility dedicated to handling potent and cytotoxic drug substances.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here